Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07699770 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Study acronym: TERMINATOR
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.
Trial Details
NCT Number NCT07699770
Lead Sponsor Tang-Du Hospital
Conditions
(from sponsor)		 Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
Related terms Neuralgia, Neuromyelitis Optica
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov